Tirzepatide, the generic version of Mounjaro, is an FDA-approved antidiabetic medication used for the treatment of type 2 diabetes and has shown promising results in studies to help with weight loss even for people without diabetes
Raijmakers R, Roerink M, Keijmel S, Joosten L, Netea M, van der Meer J, et al
Pigmentation intensity was notably reduced
Staying at your current dose for an extra 2 to 4 weeks does not reduce long-term weight loss effectiveness
This conversion to luciferin is coupled to a firefly luciferase reaction that produces a luminescent signal proportional to the amount of GSH present
What to expect in the first two weeks The most common side effects upon restarting mirror what you experienced when you first started